Journal
/
Génétique
/
A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers
Journal JoVE
Génétique
Un abonnement à JoVE est nécessaire pour voir ce contenu.  Connectez-vous ou commencez votre essai gratuit.
Journal JoVE Génétique
A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers

5,446 Views

•

10:49 min

•

September 26, 2019

DOI:

10.3791/59910-v

DOI:
10.3791/59910-v

•

10:49 min
September 26, 2019

•

2 Views
, ,
1Division of Experimental Hematology and Cancer Biology, Cancer and Blood Diseases Institute,Cincinnati Children’s Hospital Medical Center (CCHMC)

Summary

Automatically generated

The protocol details an in vitro murine carcinoma model of non-genetic defective transcription elongation. Here, chronic inhibition of CDK9 is used to repress productive elongation of RNA Pol II along pro-inflammatory response genes to mimic and study the clinically observed TEdeff phenomenon, present in about 20% of all cancer types.

Explore More Videos

CDK9 InhibitionTranscriptional Elongation DefectsTEdeff CancersImmunotherapyPharmacological ModelMurine Cell LineIn VitroIn VivoT47DCAL51FlavopiridolPolyA-positive RNAOligo DT Magnetic BeadsRibosomal RNA DepletionBinding BufferWashing BufferTris-HCl

Read Article

Cite this Article

Modur, V., Singh, N., Muhammad, B. A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers. J. Vis. Exp. (151), e59910, doi:10.3791/59910 (2019).

Download .ris file

Copy

Share Video

.

Copy